Ireland
Altratech's visionary mission is to facilitate continuous health monitoring outside clinical settings, at point-of-care facilities, and in homes. The company's pioneering technology, based on the novel Detection by Proxy concept, allows individuals to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples. Altratech's innovative approach aims to overcome common barriers associated with implementing point-of-care or home monitoring systems, particularly in sample preparation, reagent storage, and user expertise.
By leveraging molecular biology, surface chemistry, microfluidics, and chip design, Altratech is poised to enable 'Anywhere, anytime, by anyone' technology through its KeyChain PNA probe and novel Detection by Proxy. The company's strategic focus on revolutionizing molecular detection reflects its commitment to driving change in healthcare and diagnostics, positioning it as an influential player in the biotechnology landscape.
